Results 111 to 120 of about 36,570 (229)
In this territory‐wide cohort study, improving glycemic control can be observed regardless of cirrhosis status. Oral antidiabetic medication was more often used in the non‐cirrhosis group, and insulin was preferred in patients with decompensated cirrhosis, who exhibited an increasing incidence of hypoglycemia over the years and need individualized ...
Mary Yue Wang +6 more
wiley +1 more source
Impact of Breath Holding on Spleen Stiffness Measured by 100 Hz Vibration Controlled Transient Elastography. [PDF]
Atzori S, Meloni P, Arru M, Vidili G.
europepmc +1 more source
RESTORE is a prospective, double‐blind, placebo‐controlled, crossover trial evaluating Lemborexant in cirrhosis at Cipto Mangunkusumo National Referral Hospital. Both 5 and 10 mg doses reduced PSQI by week 2, with sustained benefits post‐crossover. The 5 mg group improved Stroop Test performance, whereas the 10 mg group had prolonged reaction time ...
Rino Alvani Gani +7 more
wiley +1 more source
Balloon-occluded Retrograde Transvenous Obliteration for Gastric Varices Draining into the Gastrocaval Shunt. [PDF]
Miyayama S +5 more
europepmc +1 more source
ABSTRACT Assessment of liver disease has traditionally relied on a fragmented approach involving cross‐sectional imaging, noninvasive fibrosis assessment, liver biopsy, and endoscopy for complications of portal hypertension. Although effective, this strategy often requires multiple procedures and lacks integration.
Pathipat Durongpongkasem +2 more
wiley +1 more source
Preliminary research on the effectiveness and safety of metal clip-assisted endoscopic variceal ligation in the treatment of gastric varices. [PDF]
Yi W +5 more
europepmc +1 more source
Ileal Conduit Peristomal Varices Treated via Percutaneous Transhepatic Embolization: A Case Report. [PDF]
Tiltina L, Pereira T.
europepmc +1 more source
ABSTRACT Background The acute hepatic venous pressure gradient (HVPG)‐response to i.v. propranolol predicts outcomes in patients with advanced chronic liver disease (ACLD) and clinically significant portal hypertension (CSPH). While non‐invasive tests (NIT) to monitor non‐selective beta‐blocker (NSBB)‐induced HVPG changes are lacking, spleen stiffness ...
Paul Thöne +14 more
wiley +1 more source

